Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
- PMID: 31766052
- DOI: 10.7326/M19-2125
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
Abstract
Description: The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers.
Methods: An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence.
Recommendations: This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.
Comment in
-
Breast Cancer Screening and Diagnosis.Ann Intern Med. 2020 Jun 16;172(12):840-841. doi: 10.7326/L20-0254. Ann Intern Med. 2020. PMID: 32539513 No abstract available.
-
Breast Cancer Screening and Diagnosis.Ann Intern Med. 2020 Jun 16;172(12):838-839. doi: 10.7326/L20-0253. Ann Intern Med. 2020. PMID: 32539514 No abstract available.
-
Breast Cancer Screening and Diagnosis.Ann Intern Med. 2020 Jun 16;172(12):839-840. doi: 10.7326/L20-0252. Ann Intern Med. 2020. PMID: 32539515 No abstract available.
Similar articles
-
["European Commission Initiative on Breast Cancer": Selected Breast Cancer Screening Recommendations from the European Guidelines.].Rev Esp Salud Publica. 2020 Dec 16;94:e202012179. Rev Esp Salud Publica. 2020. PMID: 33323925 Free PMC article. Spanish.
-
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency.Ann Intern Med. 2019 Aug 20;171(4):273-280. doi: 10.7326/M18-3445. Epub 2019 Jul 23. Ann Intern Med. 2019. PMID: 31330534
-
Italian guidelines for age range and test interval in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines.Radiol Med. 2024 Dec;129(12):1778-1789. doi: 10.1007/s11547-024-01900-0. Epub 2024 Oct 26. Radiol Med. 2024. PMID: 39460891
-
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer.J Med Screen. 2021 Dec;28(4):389-404. doi: 10.1177/0969141321993866. Epub 2021 Feb 25. J Med Screen. 2021. PMID: 33632023
-
ACR Appropriateness Criteria Breast Cancer Screening.J Am Coll Radiol. 2013 Jan;10(1):11-4. doi: 10.1016/j.jacr.2012.09.036. J Am Coll Radiol. 2013. PMID: 23290667 Review.
Cited by
-
NIR-II fluorescent Ag2Se polystyrene beads in a lateral flow immunoassay to detect biomarkers for breast cancer.Mikrochim Acta. 2023 Nov 9;190(12):462. doi: 10.1007/s00604-023-06039-9. Mikrochim Acta. 2023. PMID: 37945912
-
Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer.Exp Ther Med. 2022 Aug 5;24(4):616. doi: 10.3892/etm.2022.11553. eCollection 2022 Oct. Exp Ther Med. 2022. PMID: 36160901 Free PMC article.
-
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?BMC Cancer. 2022 Jun 27;22(1):705. doi: 10.1186/s12885-022-09795-8. BMC Cancer. 2022. PMID: 35761221 Free PMC article.
-
Comparison of diagnostic values of two magnetic resonance imaging (MRI) protocols for diagnosis of breast lesions.Int J Physiol Pathophysiol Pharmacol. 2022 Jun 15;14(3):193-199. eCollection 2022. Int J Physiol Pathophysiol Pharmacol. 2022. PMID: 35891931 Free PMC article.
-
A user guide to the American Society of Hematology clinical practice guidelines.Blood Adv. 2020 May 12;4(9):2095-2110. doi: 10.1182/bloodadvances.2020001755. Blood Adv. 2020. PMID: 32396622 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical